HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Aiwu Ruth He Selected Research
Aiwu Ruth He Research Topics
Disease
28
Neoplasms (Cancer)
11/2023 - 02/2008
23
Hepatocellular Carcinoma (Hepatoma)
01/2024 - 06/2012
7
Pancreatic Neoplasms (Pancreatic Cancer)
10/2020 - 08/2008
6
Fibrosis (Cirrhosis)
02/2023 - 06/2012
4
Liver Diseases (Liver Disease)
01/2024 - 04/2018
4
Disease Progression
10/2021 - 04/2014
3
Liver Neoplasms (Liver Cancer)
01/2021 - 02/2008
2
Biliary Tract Neoplasms (Biliary Tract Cancer)
11/2023 - 10/2021
2
Carcinogenesis
02/2023 - 01/2022
2
Inflammation (Inflammations)
01/2022 - 04/2018
2
Infections
01/2020 - 12/2019
2
Adenocarcinoma
01/2019 - 04/2017
1
Liver Failure
11/2023
1
Cholangiocarcinoma
11/2023
1
Neoplasm Metastasis (Metastasis)
03/2023
1
Non-alcoholic Fatty Liver Disease
03/2022
1
Liver Cirrhosis (Hepatic Cirrhosis)
03/2022
1
Hematologic Neoplasms (Hematological Malignancy)
01/2022
1
Thrombocytopenia (Thrombopenia)
10/2021
1
Heart Arrest (Cardiac Arrest)
10/2021
1
Neutropenia
10/2021
1
Pulmonary Embolism
10/2021
1
Sepsis (Septicemia)
10/2021
1
Hypertension (High Blood Pressure)
01/2020
1
Autoimmune Hepatitis
01/2020
1
Cholangitis
01/2020
1
Proteinuria
01/2020
1
Hepatitis
01/2020
1
Pancreatitis
01/2020
1
Colitis
01/2020
1
Hepatitis C
12/2019
1
Virus Diseases (Viral Diseases)
12/2019
1
Hepatitis B
12/2019
Drug/Important Bio-Agent (IBA)
6
Sorafenib (BAY 43-9006)
FDA Link
01/2022 - 01/2013
5
Proteins (Proteins, Gene)
FDA Link
11/2023 - 11/2014
5
Monoclonal Antibodies
IBA
01/2022 - 07/2005
5
Gemcitabine
FDA Link
10/2021 - 12/2013
4
Biomarkers (Surrogate Marker)
IBA
01/2024 - 03/2016
4
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2022 - 07/2005
3
Spectrin
IBA
01/2022 - 11/2014
3
Bevacizumab (Avastin)
FDA Link
01/2022 - 07/2005
3
Transforming Growth Factor beta (TGF-beta)
IBA
01/2021 - 02/2008
3
Immune Checkpoint Inhibitors
IBA
01/2020 - 12/2019
3
Cetuximab (Erbitux)
FDA Link
01/2019 - 07/2005
3
Lapatinib (GW572016)
FDA Link
03/2016 - 05/2015
3
ErbB Receptors (EGF Receptor)
IBA
12/2015 - 08/2008
2
Programmed Cell Death 1 Receptor
IBA
02/2023 - 01/2020
2
Cholecystokinin Receptors (Cholecystokinin Receptor)
IBA
02/2023 - 03/2022
2
Proglumide (Milid)
IBA
02/2023 - 03/2022
2
atezolizumab
IBA
01/2022 - 01/2020
2
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
01/2022 - 07/2005
2
merestinib
IBA
10/2021 - 01/2019
2
Ramucirumab
IBA
10/2021 - 01/2019
2
Cisplatin (Platino)
FDA Link
Generic
10/2021 - 01/2019
2
veliparib
IBA
10/2020 - 11/2015
2
Fluorouracil (Carac)
FDA Link
Generic
10/2020 - 03/2016
2
Enzymes
IBA
01/2020 - 06/2012
2
Steroids
IBA
01/2020 - 01/2020
2
Phosphotransferases (Kinase)
IBA
01/2019 - 12/2015
2
DNA (Deoxyribonucleic Acid)
IBA
01/2018 - 05/2015
2
regorafenib
IBA
11/2017 - 04/2017
2
Capecitabine (Xeloda)
FDA Link
03/2016 - 12/2015
2
Growth Factor Receptors
IBA
12/2015 - 05/2015
2
tigatuzumab
IBA
10/2015 - 12/2013
2
TNF-Related Apoptosis-Inducing Ligand Receptors
IBA
10/2015 - 12/2013
2
Yttrium-90
IBA
01/2015 - 01/2013
1
durvalumab
IBA
11/2023
1
RNA (Ribonucleic Acid)
IBA
02/2023
1
Phosphates (Orthophosphate)
IBA
02/2023
1
Buffers
IBA
02/2023
1
Antibodies
IBA
02/2023
1
cabozantinib
IBA
01/2023
1
Ipilimumab
IBA
01/2023
1
Nivolumab
IBA
01/2023
1
3,5- diethoxycarbonyl- 1,4- dihydrocollidine
IBA
01/2022
1
Antigens
IBA
01/2022
1
Chimeric Antigen Receptors
IBA
01/2022
1
codrituzumab
IBA
01/2022
1
Cytokines
IBA
01/2021
1
Tyrosine Kinase Inhibitors
IBA
01/2021
1
Oxaliplatin (Eloxatin)
FDA Link
Generic
10/2020
1
Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)
IBA
01/2020
1
Ligases (Synthetase)
IBA
01/2020
1
Lipase (Acid Lipase)
FDA Link
01/2020
1
Immunologic Factors (Immunomodulators)
IBA
01/2020
1
Alkaline Phosphatase
IBA
01/2020
1
Immunosuppressive Agents (Immunosuppressants)
IBA
01/2020
1
Amylases
FDA Link
01/2020
1
Bilirubin
IBA
01/2020
1
Thymidylate Synthase
IBA
01/2019
1
Platinum
IBA
01/2019
1
Ribonucleotide Reductases (Ribonucleotide Reductase)
IBA
01/2019
Therapy/Procedure
26
Therapeutics
01/2024 - 07/2005
5
Drug Therapy (Chemotherapy)
11/2023 - 12/2013
2
Immunotherapy
11/2023 - 01/2021
2
Liver Transplantation
03/2023 - 01/2019
2
Radiotherapy
04/2017 - 01/2015
2
Biological Therapy
08/2008 - 07/2005
1
Hepatectomy
11/2023
1
Neoadjuvant Therapy
11/2023